Biolife Solutions (BLFS) Current Assets (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Current Assets data on file, last reported at $133.2 million in Q1 2026.

• On a quarterly basis, Current Assets rose 1.6% year-over-year to $133.2 million in Q1 2026; TTM through Mar 2026 was $133.2 million, a 1.6% increase from a year earlier, with the FY2025 full-year figure at $136.6 million, down 8.2% from the prior year.
• Current Assets for Q1 2026 stood at $133.2 million, down from $136.6 million in the prior quarter.
• Over the last five years, Current Assets for BLFS reached as high as $148.8 million in Q4 2024 and fell as low as $88.2 million in Q2 2024.
• Historically, Current Assets has averaged $123.1 million across 5 years, with a median of $125.4 million in 2025.
• Across the five-year window, Current Assets fell 26.69% in 2024 and surged 42.21% in 2025, its largest moves.
• Year by year, Current Assets stood at $138.5 million in 2022, then declined by 12.89% to $120.6 million in 2023, then advanced by 23.35% to $148.8 million in 2024, then slipped by 8.2% to $136.6 million in 2025, then retreated by 2.45% to $133.2 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $133.2 million in Q1 2026, $136.6 million in Q4 2025, and $126.6 million in Q3 2025.